Just a few months after Health Canada began cracking down on private clinics offering unapproved stem cell therapies, at least one U.S. clinic has moved in to fill the vacuum with direct marketing to Canadian consumers.
The clinic from Burlington, Vermont, even offers shuttle buses to transport people from Ottawa to the clinic four hours away for treatment it suggests will end joint pain, among other things. Lunch and dinner are free, but each injection costs $6,880. Two for $10,880.
The treatments, using umbilical cord-derived mesenchymal stem cells, are not approved in either Canada or the United States. Health Canada warns that Canadians who travel abroad for stem cell treatments may put themselves at risk.
While stem cells, which were discovered at the University of Toronto in 1961 by James Till and Ernest McCulloch, promise to revolutionize many treatments and could offer breakthroughs for diseases, almost all are still considered experimental and have yet to be proven safe or effective. Clinical trials on numerous potential stem cell therapies are under way, including in Ottawa.
While research progresses, private stem cell clinics have popped up around the world making promises for treatments not yet proven safe or effective.
A 2018 study by Leigh Turner of the University of Minnesota Center for Bioethics found 43 clinics offering stem cell treatments in Canada and 750 in the U.S. Earlier this year, Health Canada sent Canadian clinics, including some in Ottawa, cease-and-desist letters.
Clinics in Vermont, near the Canadian border, appear to have ramped up marketing to Canadians since then. One clinic has been holding back-to-back seminars. Another says it stopped marketing in Canada after receiving a warning from Health Canada.
There have been cases of harm as a result of treatments, including two women who had permanent damage to their sight after stem cells were injected into their eyes at a Florida clinic. Other patients have been infected with unsterilized equipment and others have developed tumours at the site of stem cell injections.
A common harm, critics say, is exploitation.
Dr. Michael Rudnicki is director of the regenerative medicine program and Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute, says of stem cell therapy claims: If it sounds too good to be true, it probably is too good to be true.jpg
Health officials say the clinics are misusing the promise of stem cell therapy to exploit vulnerable patients.
These patients are in pain and they are suffering and they are looking for help and they are being exploited, said Dr. Michael Rudnicki, director of the regenerative medicine program and Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute.
If it sounds too good to be true, it probably is too good to be true.
At a recent seminar at a west-end Ottawa hotel meeting room, Roseanna Ammendolea of the Vermont Center for Regenerative Medicine told a packed room that her clinic and others like it had successfully treated people for pain related to arthritis, neuropathy and other ailments that affected joints using mesenchymal stem cells from umbilical cords. The stem cells, she claimed, are both effective and safe, saying there had been no issues with cell rejection.
We will not give injections if we feel that this injection will not be beneficial to our patients. This is why we are so successful.
Participants, including some who walked with canes and others who talked about being in pain and having mobility issues, were shown videos of people described as Canadian clients who claimed the treatments worked. One man said it was probably the best money I have spent in my life as far as my health. Another said she would do it again in a heartbeat and was able to do things she hadnt been able to do earlier.
They were also shown a slide showing long wait times for hip and knee replacements in Ontario, We are not a priority, she said. Where does that leave us? Participants werent told exactly how the stem cells were supposed to work, but claimed they had successfully improved pain and mobility issues in clients.
What the seminar goers werent told is that, even in the U.S., the treatment is not covered by health insurance because it remains unproven.
The U.S. Federal Drug Administration has issued a warning to consumers not to use cell therapies that are unapproved or unproven.
Stem cells have been called everything from cure-alls to miracle treatments. But dont believe the hype. Some unscrupulous providers offer stem cell products that are both unapproved and unproven. So beware of potentially dangerous procedures and confirm whats really being offered before you consider anytreatment, the FDA said in a statement.
The only stem-cell-based products that are FDA-approved for use in the United States are blood-forming stem cells derived from cord blood for limited use in patients with disorders affecting the body system that is involved in the production of blood. Bone marrow is also used for these treatments, but is generally not regulated by the FDA for that use.
Health Canada has granted market authorization for a stem cell therapy to treat graft-versus-host disease and two cell-based gene therapies to treat certain cancers. Most cell therapies are still experimental.
I totally understand the skepticism of it, Doug Argento, who works at the Vermont Center for Regenerative Medicine, said in a telephone interview, but the fact is that things that are approved now and medically paid for were seen as renegade 20 or 30 years ago.
The treatment employs technology developed by Neil Riordan, founder, chairman and chief science officer of the Stem Cell Institute in Panama, using human umbilical cord tissue-derived mesenchymal stem cells. There are 41 such clinics across the U.S. Riordan also played a role in the development of a nutritional product called Stem-Kine, which producers claim without scientific backing increases the number of stem cells circulating in a persons body.
The stem cells injected in the clinic, Argento said, are from umbilical cord tissue as a result of caesarean births to reduce risk of infection.
Rudnicki, of The Ottawa Hospital Research Institute, says there is no evidence that these sorts of cells are regenerative at all. It would not pass muster in Canada.
The public has to understand that there are people out to remove them from their money.
Rudnicki says he regularly receives inquiries from people desperate to get stem cell treatments. He says he tries to connect them with clinical trials that they might be able to participate in.
Rudnicki noted there were multiple clinical trials in Canada, including treatments of autoimmune diseases, trials involving treatment for Type 1 diabetes and others.
But the use of these inappropriate cell types for treating arthritis and joints and so on is certainly not approved by Health Canada and would not be allowed in Canada under the regulations.
There is some evidence that injections of some stem cell products might have a temporary positive impact on inflammation, he said, but it will not be regenerative and will not restore function to joints. They are being sold a bill of goods.
Leigh Turner of the University of Minnesota Center for Bioethics, meanwhile, says the explosion in clinics offering unproven stem cell therapies in the U.S. is a marketplace that traffics in misrepresentation. It is easy to see how people are taken advantage of and scammed.
It is also difficult to find out about physical harms being done to patients.
There are no safety studies. We dont have good data. But we do know there have been some serious harms.
Stem cell therapies have the potential to become standard treatment in some areas, but they are not there yet, Turner said.
Businesses are tapping into genuine human suffering, desperation and also hope.
Turner also noted there was an excellent chance that the vials of liquid being injected into patients did not actually contain stem cells.
Dr. Jonathan Fenton of another stem cell clinic in Burlington, the Vermont Regenerative Medicine, said he had complained about the new clinic, the Vermont Center for Regenerative Medicine, which has a similar name and employs hard-sell tactics, he said.
His clinic takes bone marrow from patients hips and injects it. The procedure is done the same day. He says he regularly sees Canadian patients for bone marrow aspiration therapy and platelet-rich plasma treatments, using their own blood. The treatments, he says, speed healing and are allowed in the U.S. The use of bone marrow aspiration is neither proven nor allowed in Canada.
Fenton, who is secretary-treasurer of the American Academy of Orthopedic Medicine, acknowledged many people offering stem cell treatments are not doing it to the highest ethical standards.
He has filed complaints with state officials over clinics selling unsafe or fraudulent treatments. I have asked the state and federal judiciary to close down this clinic for committing fraud.
He said his platelet and bone marrow treatments were covered by a major Vermont health insurer because they saw the cost of benefits were going down and patients were requiring fewer surgeries.
He said he was told by Health Canada that he could not market in Canada. Representatives of the Vermont Center for Regenerative Medicine, meanwhile, said they had discussions with Health Canada about what they could and could not say when marketing in Canada before holding seminars in Ottawa and Halifax.
We have looked at the information provided and have not identified any immediate non-compliance with advertising regulations pertaining to Canadian health products, a Health Canada spokesperson said, adding that the agency was continuing to assess.
Back at a west-end Ottawa hotel, some participants in the seminar, including a retired pharmacist, said they were considering getting the treatments. But its expensive.
Another participant said he was skeptical. They seemed very sketchy when I went online.
ALSO IN THE NEWS
Hoffman and Kaushic: Were losing the fight against superbugs
Super-agers, who live to at least 110, boast stronger immune systems, helping them fight off diseases
Spinal-cord stimulator really promising: Survivor moves legs for first time since Humboldt bus crash
- Home Page of the Human Gene and Cell Therapy Center [Last Updated On: August 29th, 2015] [Originally Added On: August 29th, 2015]
- Gene Therapy: Chinese Researching Gene Replacement [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Medi-Cal: Medi-Cal Update - Clinics and Hospitals | May ... [Last Updated On: November 23rd, 2016] [Originally Added On: November 23rd, 2016]
- Gene Therapy Market - Size, Share, industry, Forecast ... [Last Updated On: November 30th, 2016] [Originally Added On: November 30th, 2016]
- Digital Journal: A Global Digital Media Network - Digital Journal (press release) [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Cure for ageing could lie in gene therapy | WIRED UK [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Advanced Gene-Targeted Therapies - Alternative Cancer Clinics [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Alternative Cancer Clinics - Immunotherapy for Cancer [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Stem cell therapies breaking barriers - Guardian (blog) [Last Updated On: July 9th, 2017] [Originally Added On: July 9th, 2017]
- Cancer Biological Therapy market is rising with potential rate at CAGR of 4.7 % till 2023 - MENAFN.COM [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Head and Neck Cancer Therapeutics Market is Expected to Generate Huge Profits by 2024 - MilTech [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- In a first, scientists edit fatal gene mutation out of DNA - Asheboro Courier Tribune [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Proton Therapy: How It Could Change The Outcome of Paediatric Cancer - HuffPost [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Wilson's Disease Market: Unmet Needs of Patient Population to Inspire Players for Improved Treatment Options - Edition Truth [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Cardiovascular disease cure? One session of THIS could help treat condition - Express.co.uk [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Understanding the muscle behind global duchenne muscular dystrophy market - WhaTech [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Biological bypass shows promise in coronary artery disease - Medical Xpress [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- Sodium Iodide Symporter for Nuclear Molecular Imaging and ... [Last Updated On: August 13th, 2017] [Originally Added On: August 13th, 2017]
- Traditional Therapy Clinics Ltd (TTC.AX) Money Flow Index Levels in Focus - Stock Daily Review [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Gene Editing in Human Embryos Leaps ForwardHere's the Science - Singularity Hub [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Global Cancer Biological Therapy Market 2017 Size, Development Status, Type and Application, Segmentation ... - Digital Journal [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Orphan Diseases Market Key Players analysis ... - Digital Journal - Digital Journal [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- New Stanford drug saves child with deadly genetic disease - The Mercury News [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- Australian Market Declines - Markets Insider [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- How one California county is fighting high-priced surgeries - Los Angeles Times [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- New 'hit-and-run' gene editing tool temporarily rewrites genetics to treat cancer and HIV - GeekWire [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Global Cancer Biological Therapy Analysis & Forecast 2016 to 2023 - Digital Journal [Last Updated On: September 5th, 2017] [Originally Added On: September 5th, 2017]
- FDA Approves New Cancer Treatment - Alive For Football [Last Updated On: September 5th, 2017] [Originally Added On: September 5th, 2017]
- FDA approves first cell-based gene therapy for use in the United States - Gears Of Biz [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Quick Hits: Withdrawn Leukemia Drug Returning, Drugmaker in $58M Settlement Over Sales Reps, and More - MedShadow (registration) (blog) [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Hacking Your Genes Has Never Been Easier - Outside Magazine [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- resurrection-clinics.eu [Last Updated On: August 24th, 2018] [Originally Added On: August 24th, 2018]
- Cell and Gene Therapy Center - IQVIA [Last Updated On: December 24th, 2018] [Originally Added On: December 24th, 2018]
- F.D.A. Speeds Review of Gene Therapies, Vowing to Target ... [Last Updated On: February 17th, 2019] [Originally Added On: February 17th, 2019]
- Nutrition : The Addiction Recovery Guide [Last Updated On: March 25th, 2019] [Originally Added On: March 25th, 2019]
- Gene Therapy: The New Frontier for Inherited Retinal Disease [Last Updated On: April 16th, 2019] [Originally Added On: April 16th, 2019]
- 4 Barriers To Cell And Gene Therapy Development For Rare ... [Last Updated On: May 18th, 2019] [Originally Added On: May 18th, 2019]
- Google Bans Advertising on Unproven Medical Treatments (like Stem Cells) - Bedford Bulletin [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Biological Product Manufacturing Market Analysis, Size, Regional Outlook, Share, Trend, Growth, Analysis and Forecast - Rapid News Network [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Precision Cancer Therapies Market to Witness Comprehensive Growth by 2017 2025 - Technology Trend [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Targeted Cancer Therapies Market Regional Landscape, Production, Sales & Consumption Status and Prospects 2025 - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Chemotherapy Drugs Market Strategies, Major Industry Participants, Marketing Channels and Forecast To2018 2028 - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Texas State To Expand Round Rock Campus Programs, Services - Round Rock, TX Patch [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Transfusion-dependent Anemia Treatment Market Size, Status and Growth Opportunities by 2025 - The Market Plan [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Google bans ads for 'bad actors' selling 'deceptive treatments' - BioEdge [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Precision Cancer Therapies Market Forecast Research Reports Offers Key Insights 2017 2025 - Space Market Research [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Prospective Study Characterizes PCa Risk Linked to BRCA1, BRCA2 Mutations - Renal and Urology News [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Nearly Half of Poland's SMA Patients on Track to Get Spinraza, Experts Say - SMA News Today [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Pollard and Norris in the race for Pos. 2 of the Public Hospital District 4 - Snoqualmie Valley Record [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Social Impact Heroes: How Lynn OConnor Vos and the Muscular Dystrophy Association are helping to raise billions of dollars to fund research to... [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Non-viral Gene Therapy will now accelerate cancer study - Industry Reporter [Last Updated On: September 28th, 2019] [Originally Added On: September 28th, 2019]
- Transfusion-dependent Anemia Treatment Market Gain Impetus due to the Growing Demand over 2019 2029 - Herald Space [Last Updated On: October 1st, 2019] [Originally Added On: October 1st, 2019]
- Parkinsons Disease Treatment Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2025 - The Ukiah Post [Last Updated On: October 11th, 2019] [Originally Added On: October 11th, 2019]
- The Patient Perspective On Patient Centricity Insights From A Veteran Of 5 Clinical Trials - Clinical Leader [Last Updated On: October 12th, 2019] [Originally Added On: October 12th, 2019]
- Deepak Chopra Has Never Been Sick - The New Yorker [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Dr Batra's have launched a new genetics-based therapy that predicts future diseases - Gulf Today [Last Updated On: October 31st, 2019] [Originally Added On: October 31st, 2019]
- Davenport & Company Upped By $3.56 Million Its Sgmo (SGMO) Holding; EMPOWER CLINICS ORDINARY SHARES (EPWCF) Shorts Raised By 2360% - MS Wkly [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Global Cell Therapy Technologies Market Industry Analysis And Forecast (2018-2026) - The Market Expedition [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Tip Sheet: A clever way to make an AIDS vaccine; how a common cancer mutation actually drives cancer; and a new process that regulates red blood cell... [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Anti-Aging Products and Therapies Market Outlook: Investors Still Miss the Big Assessment - The Market Journal [Last Updated On: November 11th, 2019] [Originally Added On: November 11th, 2019]
- Abuse in cell banking services a global problem - Bioprocess Insider - BioProcess Insider [Last Updated On: November 14th, 2019] [Originally Added On: November 14th, 2019]
- Hemophilia Treatment Market Dynamics, Pin-Point Analysis, Comprehensive Landscape, Demand Key Factors, Market Segments Regions, Therapy For Hemophilia... [Last Updated On: November 18th, 2019] [Originally Added On: November 18th, 2019]
- Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT - Yahoo Finance [Last Updated On: November 20th, 2019] [Originally Added On: November 20th, 2019]
- Macular Degeneration Treatment Market and its Future Outlook and Trend During the Period of 2019 2026 - The Chicago Sentinel [Last Updated On: November 25th, 2019] [Originally Added On: November 25th, 2019]
- Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference - Thehour.com [Last Updated On: November 28th, 2019] [Originally Added On: November 28th, 2019]
- Global Parkinsons Disease Treatment Market 2019 Analysis by Industry Growth, Size, Share, Trends and Forecast by 2025 - Eastlake Times [Last Updated On: November 30th, 2019] [Originally Added On: November 30th, 2019]
- World AIDS Day 2019: 37.9M people worldwide were living with HIV at the end of 2018 - USA TODAY [Last Updated On: December 2nd, 2019] [Originally Added On: December 2nd, 2019]
- Precision Cancer Therapies Market Size, Status and Forecast 2025 Trends, Size, Drivers, Strategies, Products and - The Market Stats News [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Counterculture 73: Summer Jam, Timothy Leary and the Sexual Revolution - Rolling Stone [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Cancer gene therapy backed by Blackstone gets trial win - BioPharma Dive [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Parkinsons Disease Treatment Market 2019- Global Industry Analysis, by Key Players, Segmentation, Application, Demand and Forecast by 2025 - Tribunal... [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Mergers and Acquisitions Will Strengthen Payer Identity in 2020 - HealthPayerIntelligence.com [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- University of Iowa researchers say $18 million grant could soon lead to cure for rare brain disease - KCRG [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- ICMR issues guidelines for gene therapy in India - Daily Pioneer [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- US Network of Specialized Angelman Clinics to Double Thanks to New Partnership - Angelman Syndrome News [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- This was the best health news over the last decade - USA TODAY [Last Updated On: December 18th, 2019] [Originally Added On: December 18th, 2019]
- Top Providers of the Alpha Thalassemia Market gives a New Dimension easing Measurement and Quantification - GuruFocus.com [Last Updated On: December 27th, 2019] [Originally Added On: December 27th, 2019]
- Novel discovery in gene therapy to treat kidney diseases - WeForNews [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Insights on precision oncology developments in Japan and beyond - MobiHealthNews [Last Updated On: January 6th, 2020] [Originally Added On: January 6th, 2020]
- Cell Harvesting Market is Expected to Reach USD 387.9 Million by 2025| Bertin, Tomtec, Terumo BCT, HynoDent AG, Avita Medical, Argos Technologies -... [Last Updated On: January 9th, 2020] [Originally Added On: January 9th, 2020]